Garofalo Health Care SpA (MIL:GHC) 3-Year RORE % : -0.76% (As of Mar. 2026)


MIL:GHC Garofalo Health Care SpA MIL:GHC
88 GF Score
Price €5.48
GF Value €6.06
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Garofalo Health Care SpA 3-Year RORE %?

Garofalo Health Care SpA MIL:GHC +1.86% 88 3-Year RORE % is -0.76 as of Mar. 2026. GuruFocus rates MIL:GHC with a GF Score™ of 88/100 and a GF Value™ of €6.06 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks worse than 51.24% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Garofalo Health Care SpA's 3-Year RORE % for the quarter that ended in Mar. 2026 was -0.76%.

The industry rank for Garofalo Health Care SpA's 3-Year RORE % or its related term are showing as below:

MIL:GHC's 3-Year RORE % is ranked worse than
51.24% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: 0.07 vs MIL:GHC: -0.76

Garofalo Health Care SpA  (MIL:GHC) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Garofalo Health Care SpA 3-Year RORE % Related Terms


Garofalo Health Care SpA 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Garofalo Health Care SpA's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Garofalo Health Care SpA 3-Year RORE % Chart

Garofalo Health Care SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 16.08 3.49 0.69 4.55

Garofalo Health Care SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.62 -2.83 5.49 4.55 -0.76

MIL:GHC vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Garofalo Health Care SpA's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Garofalo Health Care SpA 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Garofalo Health Care SpA's 3-Year RORE % falls into.


MIL:GHC
88GF Score
Garofalo Health Care SpA MIL:GHC
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Garofalo Health Care SpA 3-Year RORE % Calculation

Garofalo Health Care SpA's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.246-0.251 )/( 0.743-0.086 )
=-0.005/0.657
=-0.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -0.76 mean?
Garofalo Health Care SpA (MIL:GHC) has a 3-Year RORE % of -0.76 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Garofalo Health Care SpA and its competitors. According to the industry distribution chart, Garofalo Health Care SpA ranks #310 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 51.2%.
Is Garofalo Health Care SpA's 3-Year RORE % too high?
Garofalo Health Care SpA's current 3-Year RORE % is -0.76. Based on the distribution chart, Garofalo Health Care SpA ranks #310 out of 605 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Garofalo Health Care SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #310 out of 605 companies for 3-Year RORE %. This places Garofalo Health Care SpA in the lower half of its industry. The industry median 3-Year RORE % is 0.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.07, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Garofalo Health Care SpA and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current 3-Year RORE % is -0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.06, compared to a current price of €5.48 — trading 9.6% below its estimated fair value. The current 3-Year RORE % is -0.76. Garofalo Health Care SpA's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current 3-Year RORE % is -0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?

Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued. The current stock price of €5.48 is trading 9.6% below its estimated GF Value™ of €6.06. GuruFocus considers Garofalo Health Care SpA to be Modestly Undervalued.

Key valuation signals for MIL:GHC:

  • 3-Year RORE %: -0.76
  • GF Value™: €6.06 vs. price of €5.48 (9.6% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Garofalo Health Care SpA Business Description

Address Piazzale Belle Arti, 6, Rome, ITA, 00196
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
88GF Score

Get the complete analysis for MIL:GHC

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.48
Price
€6.06
GF Value